Cidara Therapeutics logo

Cidara Therapeutics Share Price (NASDAQ: CDTX)

$65.34

0.11

(0.17%)

Last updated on

Check the interactive Cidara Therapeutics Stock chart to analyse performance

Cidara Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$63.90
    Today's High:$65.66

    Day's Volatility :2.68%

  • 52 Weeks Low:$10.14
    52 Weeks High:$69.36

    52 Weeks Volatility :85.38%

Cidara Therapeutics Stock Returns

PeriodCidara Therapeutics IncIndex (Russel 2000)
3 Months
188.46%
0.0%
6 Months
183.64%
0.0%
1 Year
464.11%
0.0%
3 Years
378.62%
-4.1%

Cidara Therapeutics Inc Key Stats

Check Cidara Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$65.23
Open
$65.145
Today's High
$65.66
Today's Low
$63.9
Market Capitalization
$1.7B
Today's Volume
$188.3K
52 Week High
$69.36
52 Week Low
$10.14
Revenue TTM
$0.0
EBITDA
$-133.5M
Earnings Per Share (EPS)
$-7.63
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-37.05%

Stock Returns calculator for Cidara Therapeutics Stock including INR - Dollar returns

The Cidara Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cidara Therapeutics investment value today

Current value as on today

₹5,69,046

Returns

₹4,69,046

(+469.05%)

Returns from Cidara Therapeutics Stock

₹4,63,762 (+463.76%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cidara Therapeutics Stock

-35%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cidara Therapeutics Stock from India on INDmoney has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cidara Therapeutics Inc

  • Name

    Holdings %

  • RA Capital Management, LLC

    14.48%

  • Bain Capital Life Sciences Investors, LLC

    10.76%

  • Point72 Asset Management, L.P.

    6.58%

  • COMMODORE CAPITAL LP

    5.06%

  • TCG Crossover Management, LLC

    4.33%

  • Adage Capital Partners Gp LLC

    4.26%

Analyst Recommendation on Cidara Therapeutics Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cidara Therapeutics(by analysts ranked 0 to 5 stars)

Cidara Therapeutics Share Price Target

What analysts predicted

Upside of 22.13%

Target:

$79.80

Current:

$65.34

Cidara Therapeutics share price target is $79.80, a slight Upside of 22.13% compared to current price of $65.34 as per analysts' prediction.

Cidara Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, CDTX stock has moved up by 201.6%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 17.58M → 302.0K (in $), with an average decrease of 74.2% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -23.48M → -25.71M (in $), with an average decrease of 9.5% per quarter

Cidara Therapeutics Technicals Summary

Sell

Neutral

Buy

Cidara Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Cidara Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cidara Therapeutics Inc logo
3.94%
183.64%
464.11%
378.62%
7.53%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Cidara Therapeutics Inc

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.
Organization
Cidara Therapeutics
Employees
38
CEO
Dr. Jeffrey L. Stein Ph.D.
Industry
Health Technology

Key Management of Cidara Therapeutics Inc

NameTitle
Dr. Jeffrey L. Stein Ph.D.
President, CEO & Executive Director
Dr. Leslie Tari Ph.D.
Chief Scientific Officer
Dr. Kevin M. Forrest Ph.D.
Founder & Chief Strategy Officer
Mr. Frank L. Karbe M.B.A.
Chief Financial Officer
Mr. Shane M. Ward J.D.
COO & Corporate Secretary
Dr. Preetam Shah M.B.A., Ph.D.
Principal Accounting Officer
Ms. Allison Lewis CCP, SPHR
Senior Vice President of People & Culture
Dr. Nicole Davarpanah J.D., M.D.
Chief Medical Officer
Mr. Jim Beitel M.B.A.
Chief Business Officer
Ms. Corrina Pavetto
Senior Vice President of Clinical Development

Important FAQs about investing in CDTX Stock from India :

What is Cidara Therapeutics share price today?

Cidara Therapeutics share price today is $65.34 as on at the close of the market. Cidara Therapeutics share today touched a day high of $65.66 and a low of $63.90.

What is the 52 week high and 52 week low for Cidara Therapeutics share?

Cidara Therapeutics share touched a 52 week high of $69.36 and a 52 week low of $10.14. Cidara Therapeutics stock price today i.e. is closed at $65.34, lower by 5.8% versus the 52 week high.

How to invest in Cidara Therapeutics Stock (CDTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cidara Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cidara Therapeutics Shares that will get you 0.0230 shares as per Cidara Therapeutics share price of $65.34 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cidara Therapeutics Stock (CDTX) from India?

Indian investors can start investing in Cidara Therapeutics (CDTX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cidara Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cidara Therapeutics share’s latest price of $65.34 as on August 30, 2025 at 1:29 am IST, you will get 0.1530 shares of Cidara Therapeutics. Learn more about fractional shares .

What are the returns that Cidara Therapeutics has given to Indian investors in the last 5 years?

Cidara Therapeutics stock has given 7.53% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?